Far be it from me to throw rocks at Fred Hassan's all glass houses. Hah. R-i-i-i-i-i-ght.
It is trivial, I grant you that. But this one deserves mention, just the same. Do go read the BusinessWeek article. Start to finish -- truly. This young man is apparently trying to convert from the dark side -- to the innovator role, in branded bio-science. I wish him well. But the company he has kept, since 2004, apparently -- is rather telling. Do go read -- here's a bit:
. . . .In 2011, Shkreli used $3 million raised from MSMB investors to start Retrophin. In addition to Blanton, Retrophin’s initial financial backers included the family of Fred Hassan, former CEO of pharmaceutical giant Schering-Plough, to whom Shkreli introduced himself at a pharmaceutical conference in 2004.
To realize his aspirations with Retrophin, Shkreli had to grow up in more ways than one. . . .
Just read the article. I think the two were cut from the same cloth. I'll stop there. Have a great evening, one and all!
No comments:
Post a Comment